Homoharringtonine (omacetaxine mepesuccinate)

omacetaxine mepesuccinate · Teva Branded Pharmaceutical Products R&D, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Homoharringtonine (omacetaxine mepesuccinate), covering 2014-06-03 to 2014-06-30. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML [Phase 2]

See pricing